Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa. Num. Pages Manejo clínico de las hiperprolactinemias. Clinical management of hyperprolactinemia. Visits. Download PDF. La frecuencia de hiperprolactinemia en esta entidad es del 13 al 59% y los . Artículo. B. Farzati,G. Mazziotti,G. Cuomo,M. Ressa,F. Sorvillo,G. Amato.

Author: Gulmaran Goltijas
Country: Mayotte
Language: English (Spanish)
Genre: Science
Published (Last): 18 February 2012
Pages: 456
PDF File Size: 18.34 Mb
ePub File Size: 4.8 Mb
ISBN: 192-3-26124-569-5
Downloads: 14047
Price: Free* [*Free Regsitration Required]
Uploader: Akinolkree

These symptoms are most likely to occur with initiation of treatment or when the dose is increased. Images subject to Copyright.

The cardiovascular risk associated with PHPT is attributable in large part to an increased prevalence of hypertension, obesity, glucose intolerance, and insulin resistance. Proliferaty activity and invasiveness among pituitary adenomas and carcinomas: Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.

Scanning should be repeated only if symptoms reappear or exacerbate. It has been suggested that a 16 kDa prolactin fragment may play a role in its pathophysiology. Women with amenorrhea may be treated with estrogens and should be measured for PRL levels annually. Resumption of the dopamine agonist is probably less harmful for the mother and fetus than surgery. Arc Unt Med, 28pp. However, some patients eventually need daily doses of 20—30 mg. Objective To provide practical and up-to-date recommendations for evaluation, differential diagnosis, and treatment of prolactinoma and hyperprolactinemia in various clinical settings.


Over time, the patient may have diminished energy, reduced muscle mass, and increased risk of osteopenia. The impact on clinical practice of routine screening for macroprolactin.

You can change the settings or obtain more information by clicking here. When ovulation cannot be restored in women with microprolactinomas who want to become pregnant, the use of clomiphene citrate or gonadotropin therapy is suggested. Pheochromoctyomas are catecholamine-producing tumors that originate from chromaffin cells of the adrenal medulla and the sympathetic ganglia catecholamine-secereting paragangliomas, or extra-adrenal pheochromocytomas.

GH and IGF-1 regulate somatic growth, including cardiac development and function Few studies are available regarding the treatment of hiperpdolactinemia in postmenopausal patients.

From Monday to Friday from 9 a.

Am J Med, 46pp. This is the first choice in all patients in whom treatment is indicated, even in those with campimetric deficiency. Regardless of its cause, hyperprolactinemia interferes with pulsatile GnRH secretion and inhibits LH hiperprolacinemia FSH secretion, thus causing hypogonadism in both sexes and infertility.

The Endocrine System and the Heart: A Review | Revista Española de Cardiología (English Edition)

SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Are you a health professional able to xrticulo or dispense drugs? Author information Article notes Copyright and License information Disclaimer. Prolactin suppresses malonyl-CoA concentration in human adipose tissue. Rheumatology Oxford44pp. Iberoamerican Cardiovascular Journals Editors’ Network.


It may however be considered if the mother wants to breast-feed her child and no tumor size increase has been found during pregnancy. This item has received. PA is associated with hypertension, hipsrprolactinemia dysfunction, and altered glucose metabolism.

The Endocrine System and the Heart: A Review

The outcome hipeerprolactinemia hypophysectomy for prolactinomas in the era of dopamine agonist therapy. Support Center Support Center. Osteoporosis methodology group and the osteoporosis research advisory group.

In overt hypothyroidism, impaired LV diastolic function has been demonstrated by slowed myocardial relaxation and impaired early ventricular filling. Dopamine agonist is the mainstay of management if fertility is desired or there are symptoms of estrogen deprivation or galactorrhea.